Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Schweizerische Medizinische Wochenschrift
|
December 8, 1990
[BEP-chemotherapy in patients with testicular tumors--is it worthwhile?]
U Hess, W F Jungi, R Morant, et al.
Radiologie (Heidelberg, Germany)
|
July 17, 2024
[The possible benefit of artificial intelligence in an organized population-related screening program : Initial results and perspective]
R Morant, A Gräwingholt, J Subelack, et al.
Schweizerische Medizinische Wochenschrift
|
March 9, 1991
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
R Morant, B Thürlimann, W F Jungi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer
R A Stahel, H Lacroix, J P Sculier, et al.
Cancer
|
May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland
H P Schmid, R Maibach, J Bernhard, et al.
Digestion
|
January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours
B Eriksson, E T Janson, N D Bax, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG)
C Sessa, J Wanders, M Roelvink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2006
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
A Glaus, Ch Boehme, B Thürlimann, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2010
Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCR
R Morant, V Vuaroqueaux, P A Diener, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Schweizerische Medizinische Wochenschrift
|
December 8, 1990
[BEP-chemotherapy in patients with testicular tumors--is it worthwhile?]
U Hess, W F Jungi, R Morant, et al.
Radiologie (Heidelberg, Germany)
|
July 17, 2024
[The possible benefit of artificial intelligence in an organized population-related screening program : Initial results and perspective]
R Morant, A Gräwingholt, J Subelack, et al.
Schweizerische Medizinische Wochenschrift
|
March 9, 1991
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
R Morant, B Thürlimann, W F Jungi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer
R A Stahel, H Lacroix, J P Sculier, et al.
Cancer
|
May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland
H P Schmid, R Maibach, J Bernhard, et al.
Digestion
|
January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours
B Eriksson, E T Janson, N D Bax, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG)
C Sessa, J Wanders, M Roelvink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2006
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
A Glaus, Ch Boehme, B Thürlimann, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2010
Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCR
R Morant, V Vuaroqueaux, P A Diener, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.
Page
of 7